INVION LIMITED - Announcements

4.17%

10.0¢

Market Cap $8.541M

Healthcare Biotechnology

Invion Limited is an Australia-based life science company. The Company is engaged in the... Invion Limited is an Australia-based life science company. The Company is engaged in the research and development of Photosoft technology for the treatment of a range of cancers, atherosclerosis and infectious diseases. The Company is developing Photosoft technology as a Photodynamic Therapy (PDT). PDT uses non-toxic photosensitizers and light to selectively kill cancer cells and promote an anti-cancer immune response. PDT also offers an alternative treatment option aimed at achieving complete tumor regression and long-lasting remission. PDT has also demonstrated broad-spectrum activity across multiple infectious diseases, including bacteria, fungi and viruses. It holds the Australia and New Zealand license rights and distribution rights to Hong Kong and the rest of Asia Pacific, excluding China, Macau, Taiwan and Japan, to the Photosoft technology for all cancer indications. The Company’s wholly owned subsidiary is Epitech Dermal Science Pty Ltd.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

IVX	Security Class Reinstatement to Quotation	PRICE SENSITIVE	17/07/25	125.42KB	Share
IVX	Security Class Suspension from Quotation	PRICE SENSITIVE	11/07/25	106.19KB	Share
IVX	Underwritten Loyalty Option Entitlement Offer Prospectus	PRICE SENSITIVE	23/06/25	172.73KB	Share
IVX	Loyalty Option Entitlement Offer	PRICE SENSITIVE	13/06/25	179.51KB	Share
IVX	Encouraging SRC Findings on Ph I/II Skin Cancer Trial	PRICE SENSITIVE	29/05/25	346KB	Share
IVX	Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial	PRICE SENSITIVE	02/05/25	203.21KB	Share
IVX	Appendix 4C and Quarterly Activities Report - March 2025	PRICE SENSITIVE	30/04/25	267.26KB	Share
IVX	Share Purchase Agreement Termination and Tranche Repayment	PRICE SENSITIVE	05/03/25	180.88KB	Share
IVX	Completion Of Placement to Accelerate Clinical Programs	PRICE SENSITIVE	04/03/25	219.65KB	Share
IVX	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/25	631.7KB	Share
IVX	Trading Halt	PRICE SENSITIVE	28/02/25	560.65KB	Share
IVX	Oesophageal Cancer Collaboration and Funding Agreement	PRICE SENSITIVE	26/02/25	222.54KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	31/01/25	310.2KB	Share
IVX	Invion Doses First Patient in Phase I/II Skin Cancer Trial	PRICE SENSITIVE	03/12/24	210.82KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	28/10/24	349.01KB	Share
IVX	Consolidation/Split - IVX	PRICE SENSITIVE	15/10/24	20.08KB	Share
IVX	Ph 2 Prostate Cancer Results Strong Safety and 40% Response	PRICE SENSITIVE	18/09/24	264.01KB	Share
IVX	Appendix 4E and Annual Report	PRICE SENSITIVE	30/08/24	1.24MB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	30/07/24	323.01KB	Share
IVX	Invion secures funding through an institutional placement	PRICE SENSITIVE	28/06/24	158.25KB	Share
IVX	Agreement with Major South Korean Pharma Group Hanlim	PRICE SENSITIVE	08/05/24	205.79KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	30/04/24	340.11KB	Share
IVX	INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC	PRICE SENSITIVE	04/03/24	826.98KB	Share
IVX	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	28/02/24	1.17MB	Share
IVX	Agreement with Dr.inB to develop Photosoft treatment for HPV	PRICE SENSITIVE	23/02/24	204.82KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	30/01/24	2.02MB	Share
IVX	AGM Presentation	PRICE SENSITIVE	29/11/23	12.21MB	Share
IVX	Major Milestone towards Clinical Trials	PRICE SENSITIVE	21/11/23	217.77KB	Share
IVX	Investor Presentation	PRICE SENSITIVE	24/10/23	10.57MB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	24/10/23	225.83KB	Share
IVX	Photosoft Territory Expanded to South Korea for Cancer	PRICE SENSITIVE	25/09/23	131.64KB	Share
IVX	Appendix 4E and Preliminary Financial Report	PRICE SENSITIVE	31/08/23	619.68KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	20/07/23	520.52KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	28/04/23	504.18KB	Share
IVX	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	23/02/23	745.96KB	Share
IVX	Expansion of Territory Rights to USA, Canada and Hong Kong	PRICE SENSITIVE	08/02/23	193.04KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	30/01/23	227.33KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	17/10/22	358.19KB	Share
IVX	INV043 Effective Against Anal Cancer SCC In Vitro	PRICE SENSITIVE	15/09/22	354.81KB	Share
IVX	Response to ASX Aware Query	PRICE SENSITIVE	13/09/22	424.96KB	Share
IVX	Photosoft Shows Activity Against Zika Virus	PRICE SENSITIVE	08/09/22	264.67KB	Share
IVX	Appendix 4E and Annual Report	PRICE SENSITIVE	18/08/22	1.17MB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	21/07/22	222.22KB	Share
IVX	INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY	PRICE SENSITIVE	30/05/22	1.47MB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	20/04/22	291.61KB	Share
IVX	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	22/02/22	528.52KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	20/01/22	302KB	Share
IVX	Supplementary Prospectus	PRICE SENSITIVE	25/11/21	318.35KB	Share
IVX	Prospectus	PRICE SENSITIVE	23/11/21	861.97KB	Share
IVX	Share Purchase Plan Offer Booklet & Application Form	PRICE SENSITIVE	22/11/21	525.35KB	Share
IVX	Capital Raising and expansion of Photosoft Territory	PRICE SENSITIVE	16/11/21	180.82KB	Share
IVX	Trading Halt	PRICE SENSITIVE	12/11/21	255.8KB	Share
IVX	AGM Presentation	PRICE SENSITIVE	09/11/21	1.13MB	Share
IVX	Further Information on Proof of Concept Pilot Study	PRICE SENSITIVE	29/10/21	184.02KB	Share
IVX	Complete Regression of TNBC Tumours and Protective Immunity	PRICE SENSITIVE	28/10/21	672.06KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	21/10/21	298.71KB	Share
IVX	Appendix 4E and Annual Report	PRICE SENSITIVE	05/08/21	1.07MB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	22/07/21	341.14KB	Share
IVX	Capital Raising & co-development for Photosoft Technology	PRICE SENSITIVE	02/06/21	194.58KB	Share
IVX	Trading Halt	PRICE SENSITIVE	31/05/21	265.14KB	Share
IVX	Initial Proof-of-Concept results show INV043 to be effective	PRICE SENSITIVE	25/05/21	5.47MB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	23/04/21	321.23KB	Share
IVX	App 4D and Financial Report for half year to 31 Dec 2020	PRICE SENSITIVE	25/02/21	571.76KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	21/01/21	335.39KB	Share
IVX	Activities Report and Appendix 4C	PRICE SENSITIVE	26/10/20	467.65KB	Share
IVX	Appendix 4E and Annual Report	PRICE SENSITIVE	26/08/20	1.09MB	Share
IVX	Business Update and Change to Board and Management	PRICE SENSITIVE	29/07/20	101.61KB	Share
IVX	Activities Report and Appendix 4C June 2020 Quarter	PRICE SENSITIVE	29/07/20	389.86KB	Share
IVX	Invion subsidiary signs Supply Agreement with Pavay Biotech	PRICE SENSITIVE	30/06/20	91.05KB	Share
IVX	Appendix 4C - March 2020 quarter	PRICE SENSITIVE	20/04/20	1.1MB	Share
IVX	App 4D and Financial Report for half year to 31 Dec 2019	PRICE SENSITIVE	24/02/20	321.09KB	Share
IVX	Invion signs R&D Services Agreement with Pavay Biotech	PRICE SENSITIVE	03/02/20	250.76KB	Share
IVX	Appendix 4C - December 2019 quarter	PRICE SENSITIVE	30/01/20	1019.02KB	Share
IVX	Additional Information to Prior Announcement	PRICE SENSITIVE	29/11/19	140.76KB	Share
IVX	Pre-clinical research agreement with Peter MacCallum CC	PRICE SENSITIVE	31/10/19	255.32KB	Share
IVX	Appendix 4C - September 2019 quarter	PRICE SENSITIVE	29/10/19	20.75KB	Share
IVX	Appendix 4E and Financial Report for year ended 30 June 2019	PRICE SENSITIVE	28/08/19	862.79KB	Share
IVX	COO Craig Newton to transition to Invion CEO	PRICE SENSITIVE	22/07/19	82.2KB	Share
IVX	Appendix 4C - June quarter	PRICE SENSITIVE	12/07/19	166.56KB	Share
IVX	Animal studies show IVX-P02 potential in metastatic cancers	PRICE SENSITIVE	28/05/19	84.29KB	Share
IVX	Quarterly Update	PRICE SENSITIVE	18/04/19	82.04KB	Share
IVX	Appendix 4C - March 2019 quarter	PRICE SENSITIVE	18/04/19	20.42KB	Share
IVX	Response to ASX Price Query	PRICE SENSITIVE	01/04/19	435.41KB	Share
IVX	Appendix 4D and Financial Report for Half Year to 31 Dec 18	PRICE SENSITIVE	26/02/19	317.82KB	Share
IVX	Response to ASX Appendix 4C Query	PRICE SENSITIVE	21/02/19	438.11KB	Share
IVX	Invion completes spin-out of respiratory assets	PRICE SENSITIVE	12/02/19	83.2KB	Share
IVX	General Meeting - Results of Meeting	PRICE SENSITIVE	30/01/19	136.23KB	Share
IVX	Appendix 4C - December quarter	PRICE SENSITIVE	29/01/19	172.82KB	Share
IVX	Appendix 4C - September 2018 quarter	PRICE SENSITIVE	29/10/18	95.8KB	Share
IVX	New Photosoft formulation increased effect in ovarian cancer	PRICE SENSITIVE	25/09/18	87.07KB	Share
IVX	Spin out of respiratory assets for development in China	PRICE SENSITIVE	05/09/18	98.16KB	Share
IVX	Appendix 4E Annual Report and Full Year Statutory Accounts	PRICE SENSITIVE	28/08/18	706.42KB	Share
IVX	Appendix 4C - June 2018 quarter	PRICE SENSITIVE	27/07/18	88.63KB	Share
IVX	Photosoft efficiently destroys ovarian cancer cells in vitro	PRICE SENSITIVE	05/07/18	87.03KB	Share
IVX	Appendix 4C - March 2018 quarter	PRICE SENSITIVE	26/04/18	93.93KB	Share
IVX	Response to ASX Price Query	PRICE SENSITIVE	29/03/18	493.44KB	Share
IVX	Invion alliance with Hudson Institute of Medical Research	PRICE SENSITIVE	20/03/18	83.9KB	Share
IVX	Completion iof Rights Issue	PRICE SENSITIVE	13/03/18	86.14KB	Share
IVX	Response to ASX Price Query	PRICE SENSITIVE	01/03/18	491.77KB	Share
IVX	Appendix 4D and Financial Report for half year to 31 Dec 17	PRICE SENSITIVE	28/02/18	332.83KB	Share

IVX Security Class Reinstatement to Quotation
17/07/25	PRICE SENSITIVE	125.42KB	Share
IVX Security Class Suspension from Quotation
11/07/25	PRICE SENSITIVE	106.19KB	Share
IVX Underwritten Loyalty Option Entitlement Offer Prospectus
23/06/25	PRICE SENSITIVE	172.73KB	Share
IVX Loyalty Option Entitlement Offer
13/06/25	PRICE SENSITIVE	179.51KB	Share
IVX Encouraging SRC Findings on Ph I/II Skin Cancer Trial
29/05/25	PRICE SENSITIVE	346KB	Share
IVX Dosing of 1st Six Patients in Phase I/II Skin Cancer Trial
02/05/25	PRICE SENSITIVE	203.21KB	Share
IVX Appendix 4C and Quarterly Activities Report - March 2025
30/04/25	PRICE SENSITIVE	267.26KB	Share
IVX Share Purchase Agreement Termination and Tranche Repayment
05/03/25	PRICE SENSITIVE	180.88KB	Share
IVX Completion Of Placement to Accelerate Clinical Programs
04/03/25	PRICE SENSITIVE	219.65KB	Share
IVX Appendix 4D and Half Year Financial Report
28/02/25	PRICE SENSITIVE	631.7KB	Share
IVX Trading Halt
28/02/25	PRICE SENSITIVE	560.65KB	Share
IVX Oesophageal Cancer Collaboration and Funding Agreement
26/02/25	PRICE SENSITIVE	222.54KB	Share
IVX Activities Report and Appendix 4C
31/01/25	PRICE SENSITIVE	310.2KB	Share
IVX Invion Doses First Patient in Phase I/II Skin Cancer Trial
03/12/24	PRICE SENSITIVE	210.82KB	Share
IVX Activities Report and Appendix 4C
28/10/24	PRICE SENSITIVE	349.01KB	Share
IVX Consolidation/Split - IVX
15/10/24	PRICE SENSITIVE	20.08KB	Share
IVX Ph 2 Prostate Cancer Results Strong Safety and 40% Response
18/09/24	PRICE SENSITIVE	264.01KB	Share
IVX Appendix 4E and Annual Report
30/08/24	PRICE SENSITIVE	1.24MB	Share
IVX Activities Report and Appendix 4C
30/07/24	PRICE SENSITIVE	323.01KB	Share
IVX Invion secures funding through an institutional placement
28/06/24	PRICE SENSITIVE	158.25KB	Share
IVX Agreement with Major South Korean Pharma Group Hanlim
08/05/24	PRICE SENSITIVE	205.79KB	Share
IVX Activities Report and Appendix 4C
30/04/24	PRICE SENSITIVE	340.11KB	Share
IVX INV043 With ICI Therapy Achieved 80% Tumour Control For ASCC
04/03/24	PRICE SENSITIVE	826.98KB	Share
IVX Appendix 4D and Half Year Financial Report
28/02/24	PRICE SENSITIVE	1.17MB	Share
IVX Agreement with Dr.inB to develop Photosoft treatment for HPV
23/02/24	PRICE SENSITIVE	204.82KB	Share
IVX Activities Report and Appendix 4C
30/01/24	PRICE SENSITIVE	2.02MB	Share
IVX AGM Presentation
29/11/23	PRICE SENSITIVE	12.21MB	Share
IVX Major Milestone towards Clinical Trials
21/11/23	PRICE SENSITIVE	217.77KB	Share
IVX Investor Presentation
24/10/23	PRICE SENSITIVE	10.57MB	Share
IVX Activities Report and Appendix 4C
24/10/23	PRICE SENSITIVE	225.83KB	Share
IVX Photosoft Territory Expanded to South Korea for Cancer
25/09/23	PRICE SENSITIVE	131.64KB	Share
IVX Appendix 4E and Preliminary Financial Report
31/08/23	PRICE SENSITIVE	619.68KB	Share
IVX Activities Report and Appendix 4C
20/07/23	PRICE SENSITIVE	520.52KB	Share
IVX Activities Report and Appendix 4C
28/04/23	PRICE SENSITIVE	504.18KB	Share
IVX Appendix 4D and Half Year Financial Report
23/02/23	PRICE SENSITIVE	745.96KB	Share
IVX Expansion of Territory Rights to USA, Canada and Hong Kong
08/02/23	PRICE SENSITIVE	193.04KB	Share
IVX Activities Report and Appendix 4C
30/01/23	PRICE SENSITIVE	227.33KB	Share
IVX Activities Report and Appendix 4C
17/10/22	PRICE SENSITIVE	358.19KB	Share
IVX INV043 Effective Against Anal Cancer SCC In Vitro
15/09/22	PRICE SENSITIVE	354.81KB	Share
IVX Response to ASX Aware Query
13/09/22	PRICE SENSITIVE	424.96KB	Share
IVX Photosoft Shows Activity Against Zika Virus
08/09/22	PRICE SENSITIVE	264.67KB	Share
IVX Appendix 4E and Annual Report
18/08/22	PRICE SENSITIVE	1.17MB	Share
IVX Activities Report and Appendix 4C
21/07/22	PRICE SENSITIVE	222.22KB	Share
IVX INV043 SIGNIFICANTLY IMPROVED CHECKPOINT INHIBITOR THERAPY
30/05/22	PRICE SENSITIVE	1.47MB	Share
IVX Activities Report and Appendix 4C
20/04/22	PRICE SENSITIVE	291.61KB	Share
IVX Appendix 4D and Half Year Financial Report
22/02/22	PRICE SENSITIVE	528.52KB	Share
IVX Activities Report and Appendix 4C
20/01/22	PRICE SENSITIVE	302KB	Share
IVX Supplementary Prospectus
25/11/21	PRICE SENSITIVE	318.35KB	Share
IVX Prospectus
23/11/21	PRICE SENSITIVE	861.97KB	Share
IVX Share Purchase Plan Offer Booklet & Application Form
22/11/21	PRICE SENSITIVE	525.35KB	Share
IVX Capital Raising and expansion of Photosoft Territory
16/11/21	PRICE SENSITIVE	180.82KB	Share
IVX Trading Halt
12/11/21	PRICE SENSITIVE	255.8KB	Share
IVX AGM Presentation
09/11/21	PRICE SENSITIVE	1.13MB	Share
IVX Further Information on Proof of Concept Pilot Study
29/10/21	PRICE SENSITIVE	184.02KB	Share
IVX Complete Regression of TNBC Tumours and Protective Immunity
28/10/21	PRICE SENSITIVE	672.06KB	Share
IVX Activities Report and Appendix 4C
21/10/21	PRICE SENSITIVE	298.71KB	Share
IVX Appendix 4E and Annual Report
05/08/21	PRICE SENSITIVE	1.07MB	Share
IVX Activities Report and Appendix 4C
22/07/21	PRICE SENSITIVE	341.14KB	Share
IVX Capital Raising & co-development for Photosoft Technology
02/06/21	PRICE SENSITIVE	194.58KB	Share
IVX Trading Halt
31/05/21	PRICE SENSITIVE	265.14KB	Share
IVX Initial Proof-of-Concept results show INV043 to be effective
25/05/21	PRICE SENSITIVE	5.47MB	Share
IVX Activities Report and Appendix 4C
23/04/21	PRICE SENSITIVE	321.23KB	Share
IVX App 4D and Financial Report for half year to 31 Dec 2020
25/02/21	PRICE SENSITIVE	571.76KB	Share
IVX Activities Report and Appendix 4C
21/01/21	PRICE SENSITIVE	335.39KB	Share
IVX Activities Report and Appendix 4C
26/10/20	PRICE SENSITIVE	467.65KB	Share
IVX Appendix 4E and Annual Report
26/08/20	PRICE SENSITIVE	1.09MB	Share
IVX Business Update and Change to Board and Management
29/07/20	PRICE SENSITIVE	101.61KB	Share
IVX Activities Report and Appendix 4C June 2020 Quarter
29/07/20	PRICE SENSITIVE	389.86KB	Share
IVX Invion subsidiary signs Supply Agreement with Pavay Biotech
30/06/20	PRICE SENSITIVE	91.05KB	Share
IVX Appendix 4C - March 2020 quarter
20/04/20	PRICE SENSITIVE	1.1MB	Share
IVX App 4D and Financial Report for half year to 31 Dec 2019
24/02/20	PRICE SENSITIVE	321.09KB	Share
IVX Invion signs R&D Services Agreement with Pavay Biotech
03/02/20	PRICE SENSITIVE	250.76KB	Share
IVX Appendix 4C - December 2019 quarter
30/01/20	PRICE SENSITIVE	1019.02KB	Share
IVX Additional Information to Prior Announcement
29/11/19	PRICE SENSITIVE	140.76KB	Share
IVX Pre-clinical research agreement with Peter MacCallum CC
31/10/19	PRICE SENSITIVE	255.32KB	Share
IVX Appendix 4C - September 2019 quarter
29/10/19	PRICE SENSITIVE	20.75KB	Share
IVX Appendix 4E and Financial Report for year ended 30 June 2019
28/08/19	PRICE SENSITIVE	862.79KB	Share
IVX COO Craig Newton to transition to Invion CEO
22/07/19	PRICE SENSITIVE	82.2KB	Share
IVX Appendix 4C - June quarter
12/07/19	PRICE SENSITIVE	166.56KB	Share
IVX Animal studies show IVX-P02 potential in metastatic cancers
28/05/19	PRICE SENSITIVE	84.29KB	Share
IVX Quarterly Update
18/04/19	PRICE SENSITIVE	82.04KB	Share
IVX Appendix 4C - March 2019 quarter
18/04/19	PRICE SENSITIVE	20.42KB	Share
IVX Response to ASX Price Query
01/04/19	PRICE SENSITIVE	435.41KB	Share
IVX Appendix 4D and Financial Report for Half Year to 31 Dec 18
26/02/19	PRICE SENSITIVE	317.82KB	Share
IVX Response to ASX Appendix 4C Query
21/02/19	PRICE SENSITIVE	438.11KB	Share
IVX Invion completes spin-out of respiratory assets
12/02/19	PRICE SENSITIVE	83.2KB	Share
IVX General Meeting - Results of Meeting
30/01/19	PRICE SENSITIVE	136.23KB	Share
IVX Appendix 4C - December quarter
29/01/19	PRICE SENSITIVE	172.82KB	Share
IVX Appendix 4C - September 2018 quarter
29/10/18	PRICE SENSITIVE	95.8KB	Share
IVX New Photosoft formulation increased effect in ovarian cancer
25/09/18	PRICE SENSITIVE	87.07KB	Share
IVX Spin out of respiratory assets for development in China
05/09/18	PRICE SENSITIVE	98.16KB	Share
IVX Appendix 4E Annual Report and Full Year Statutory Accounts
28/08/18	PRICE SENSITIVE	706.42KB	Share
IVX Appendix 4C - June 2018 quarter
27/07/18	PRICE SENSITIVE	88.63KB	Share
IVX Photosoft efficiently destroys ovarian cancer cells in vitro
05/07/18	PRICE SENSITIVE	87.03KB	Share
IVX Appendix 4C - March 2018 quarter
26/04/18	PRICE SENSITIVE	93.93KB	Share
IVX Response to ASX Price Query
29/03/18	PRICE SENSITIVE	493.44KB	Share
IVX Invion alliance with Hudson Institute of Medical Research
20/03/18	PRICE SENSITIVE	83.9KB	Share
IVX Completion iof Rights Issue
13/03/18	PRICE SENSITIVE	86.14KB	Share
IVX Response to ASX Price Query
01/03/18	PRICE SENSITIVE	491.77KB	Share
IVX Appendix 4D and Financial Report for half year to 31 Dec 17
28/02/18	PRICE SENSITIVE	332.83KB	Share

REFRESH

1 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 10.0¢		Change 0.004(4.17%)		Mkt cap ! $8.541M

Open	High	Low	Value	Volume
9.7¢	10.0¢	9.6¢	$6.613K	66.75K

Buyers (Bids)

No.	Vol.	Price($)
1	75887	9.6¢

Sellers (Offers)

Price($)	Vol.	No.
10.0¢	294638	3

View Market Depth

No.	Vol.	Price($)
1	75887	0.096
2	60000	0.095
1	47000	0.094
1	25000	0.093
1	42667	0.092

Price($)	Vol.	No.
0.100	294638	3
0.105	22162	2
0.110	28153	1
0.115	58455	2
0.120	20233	2

Last trade - 15.14pm 30/07/2025 (20 minute delay)

IVX (ASX) Chart

INVION LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available